Study of Alkotinib in Patients With Advanced Non Small Cell Lung Cancer
Clinical trial NCT03607188 · COMPLETED
Trial details
- NCT number
- NCT03607188
- Sponsor
- Suzhou Zelgen Biopharmaceuticals Co.,Ltd
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-18
- Primary completion
- 2022-10-17
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.